MedTrace Logo

Improving Retention of Hispanics Receiving Antidepressant Therapy

NCT00057642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-08-20

No results posted yet for this study

Summary

This study will develop an intervention that will increase the retention of Hispanics with major depression in antidepressant therapy.

Conditions

Interventions

DRUG

Sertraline

DRUG

Venlafaxine Extended Release

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Roberto Lewis-Fernandez, MD · Columbia University, NY State Psychiatric Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2006-08-31
Completion
2006-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00057642 on ClinicalTrials.gov